These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27232229)

  • 21. Coagulation factor XIII in plasma of patients with benign and malignant gynaecological tumours.
    van Wersch JW; Peters C; Ubachs JM
    Eur J Clin Chem Clin Biochem; 1994 Sep; 32(9):681-4. PubMed ID: 7865623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Disorders of hemostasis in liver cirrhosis. 2. Therapy].
    Neidhardt B; Schricker KT
    Fortschr Med; 1982 May; 100(18):836-40. PubMed ID: 6178666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between oxidized fibrinogen and hemostasis disturbances and endothelial dysfunction in myocardial infarction.
    Ragino YI; Baum VA; Polonskaya YV; Sadovski EV; Baum SR; Nikitin YP
    Bull Exp Biol Med; 2008 Apr; 145(4):412-4. PubMed ID: 19110580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics of the effect of thrombin on macromolecular substrates].
    Sereiskaia AA; Strukova SM
    Dokl Akad Nauk SSSR; 1985; 282(2):481-4. PubMed ID: 4017865
    [No Abstract]   [Full Text] [Related]  

  • 25. [Plasma and plasma fractions in the therapy of blood coagulation disorders].
    Lechler E
    Internist (Berl); 1974 Sep; 15(9):461-4. PubMed ID: 4609113
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of anesthesia on blood coagulation factor XIII].
    Homann B; Blumenberg D; Lerner H
    Anaesthesist; 1984 Mar; 33(3):145-8. PubMed ID: 6721127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The anticoagulant system following intravenous administration of factor XIII and thromboplastin].
    Liapina LA; Ul'ianov AM; Zhitnikova ES
    Fiziol Zh SSSR Im I M Sechenova; 1976 Aug; 62(8):1166-70. PubMed ID: 992139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII.
    Chan KYT; Yong ASM; Wang X; Ringgold KM; St John AE; Baylis JR; White NJ; Kastrup CJ
    Sci Rep; 2020 Nov; 10(1):20116. PubMed ID: 33208779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)].
    Klingemann HG; Brunswig D; Liehr H
    Z Gastroenterol; 1978 Sep; 16(9):564-73. PubMed ID: 706517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor XIII consumption as an indicator of thrombin generation.
    Triantaphyllopoulos DC
    J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844
    [No Abstract]   [Full Text] [Related]  

  • 31. Ligation of fibrinogen by factor XIIIa with dithiothreitol: mechanical properties of ligated fibrinogen gels.
    Shimizu A; Ferry JD
    Biopolymers; 1988 Apr; 27(4):703-13. PubMed ID: 2897211
    [No Abstract]   [Full Text] [Related]  

  • 32. [Importance of factor XIII for hemostasis and wound healing].
    Haanen C
    Ned Tijdschr Geneeskd; 1972 Mar; 116(11):448-54. PubMed ID: 4551649
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains.
    Siebenlist KR; Meh DA; Mosesson MW
    Biochemistry; 1996 Aug; 35(32):10448-53. PubMed ID: 8756701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Packaging zinc, fibrinogen, and factor XIII in platelet alpha-granules.
    Marx G; Korner G; Mou X; Gorodetsky R
    J Cell Physiol; 1993 Sep; 156(3):437-42. PubMed ID: 8360253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemostatic problems in liver surgery.
    Rö JS
    Scand J Gastroenterol Suppl; 1973; 19():71-81. PubMed ID: 4577801
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in the properties of fibrinogen as a result of blood loss].
    Zhankina GKh
    Vestn Khir Im I I Grek; 1972 Sep; 109(9):80-3. PubMed ID: 4664064
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fibrinogen (fibrin), factor VIII and factor XIII in children with various renal disease (author's transl)].
    Kamitsuji H; Tani K; Masuyama H; Ichikawa M; Taniguchi A; Takeuchi Y; Iwagaki K
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):23-40. PubMed ID: 6770133
    [No Abstract]   [Full Text] [Related]  

  • 38. Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.
    Vaziri ND; Gonzales E; Barton CH; Chen HT; Nguyen Q; Arquilla M
    J Lab Clin Med; 1991 Feb; 117(2):152-6. PubMed ID: 1993857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen.
    Krarup A; Gulla KC; Gál P; Hajela K; Sim RB
    Biochim Biophys Acta; 2008 Sep; 1784(9):1294-300. PubMed ID: 18456010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the physiological changes of blood coagulation factor XIII during pregnancy and their significance (author's transl)].
    Hayano Y; Imai N; Karasawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Apr; 34(4):469-77. PubMed ID: 7069252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.